Ambitious £24 million plans for a brand-new home for Oldham Coliseum have officially been submitted this week.
After the historic theatre in the heart of Oldham announced its shock closure with a heartbreaking statement due to a loss of funding earlier this year, Oldham Council went on to unveil its vision for the future of Oldham Coliseum back in June, and even shared a few photos of what the impressive new cultural hub could look like.
With a design that’s been influenced by surrounding historical buildings, and using materials to “complement” the town’s current architecture, the Council says the plans for the “modern and accessible” theatre make it both suitable for the audiences of today, all while in keeping with Oldham’s proud history.
A main auditorium with seating for more than 300 people, a 120-seat studio theatre, an education suite, and a number of all-day café bar areas – which can also be used as additional performance spaces – all form part of the £24 million masterplan.
Plans for Oldham Coliseum’s £24m ‘new home’ have officially been submitted / Credit: Oldham Council
And now, those “ambitious” plans have officially been submitted this week – with a decision due to be made on the application by November.
ADVERTISEMENT
Set to take shape and form a focal point of Oldham’s new outdoor arts and performance space, the “new home” for Oldham Coliseum would be open from morning into the evening, and won’t just be a place for performances and theatre, according to the Council, but also a place where people can “meet up and socialise”.
The Council also hopes the exciting new theatre will boost the town’s night time economy.
ADVERTISEMENT
The plans form a focal point of Oldham’s new outdoor arts and performance space / Credit: Oldham Council
Speaking as the £24 million plans were submitted for approval this week, Cllr Arooj Shah, who is the Leader of Oldham Council, said: “This is such an exciting next step for Oldham Coliseum, theatregoers in Oldham and beyond, and everyone involved who has helped bring this new theatre to life.
“Oldham has such a fantastic heritage of theatre and production spanning back decades, so it’s important we continue this for future generations.
“It’s also important to remember that this new space won’t just be a theatre.
ADVERTISEMENT
“It will be a place that encourages people to come together with friends and family to get creative, socialise with one another and celebrate the arts [and] I personally can’t wait to see our new theatre throw open its doors.”
A formal decision is due to be made on the plans by November 2023 / Credit: Oldham Council
Duncan Craig OBE, Chair of Trustees, Oldham Coliseum’s Chair of Trustees, Duncan Craig, has also called the formal submitting of the plans this week “another exciting step forward”.
But he admitted that there’s “still a journey ahead”.
“The success of the theatre will only happen if we work together and show just exactly what a mighty Coliseum can be,” he concluded.
Featured Image – Oldham Council
News
New endometriosis pill helping hundreds of women with ‘debilitating’ condition to be made available on NHS
Emily Sergeant
A groundbreaking new pill to help women with a ‘debilitating’ condition is set to be made available on the NHS.
The new daily pill for endometriosis – which has been approved for use on the NHS in England by the National Institute for Health and Care Excellence (NICE) – is called linzagolix, and will be available for those who have had previous treatment for endometriosis, working to manage any symptoms they may be experiencing.
Around 1.5 million women in the UK are thought to be currently living with endometriosis.
Endometriosis can cause chronic pain, heavy periods, and extreme tiredness when tissue similar to the womb lining grows elsewhere in the body.
A new daily pill for endometriosis has been approved for use on the NHS, and could help over a thousand women in England every year manage the symptoms of the debilitating condition.
As mentioned, linzagolix will be available specifically for patients whose previous medical or surgical treatments for endometriosis have been unsuccessful, and will be given alongside ‘add-back’ hormone therapy – which involves using low-dose hormone replacement therapy (HRT) to prevent menopause-like symptoms and bone loss.
This is the second take-at-home treatment to be approved to treat endometriosis on the NHS, and it’s thought that more than 1,000 women will benefit.
In clinical trials, linzagolix was shown to be successful in reducing painful periods and non-menstrual pelvic pain, compared with placebo, hence why it has been approved on the NHS by NICE.
“This is welcome news for women with endometriosis who haven’t found relief from previous therapies or surgery,” commented Dr Sue Mann, who is the National Clinical Director in Women’s Health for NHS England.
“It’s another treatment option which will help women take control of their health and better manage the symptoms of this often painful and debilitating condition.
“This is a testament to our ongoing commitment to improving treatment, care and quality of life for women.”
Featured Image – Heute
News
Wigan woman jailed after hitting pedestrian in Fiat 500 while driving high on nitrous oxide ‘balloons’
Emily Sergeant
A young woman from Wigan has been handed jail time after hitting a pedestrian while driving high on nitrous oxide.
Louisa Tunstall was driving a white Fiat 500 towards the East Lancashire Road in Wigan at around 7pm on Friday 24 May 2024 – a time when traffic conditions were said to be ‘quiet’ – but Tunstall was under the influence of a now-banned drug, nitrous oxide, at the time of the incident, Greater Manchester Police (GMP) confirmed.
While driving under the influence, 19-year-old Tunstall veered to the left onto the pavement and collided with a 51-year-old woman pedestrian.
After striking the woman, the car then overturned and, in the process, caused serious life-changing injuries.
When questioned by police, Tunstall stated that she ‘took her eyes off the road’ to retrieve something in the footwell before knowing the car had flipped, but she also confirmed that she had just been out to purchase nitrous oxide to use that evening.
After obtaining witness accounts, investigating officers were able to track down nearby CCTV footable which showed Tunstall inhaling nitrous oxide through a balloon whilst driving, seconds before the collision occurred.
#JAILED | It's not a laughing matter when you get behind the wheel under the influence of drugs.
Now Louisa Tunstall has to spend over a year behind bars after inhaling nitrous oxide and causing serious injury in #Wigan last year.
— Greater Manchester Police (@gmpolice) May 14, 2025
Further investigation by GMP’s Forensic Vehicle Examination Unit examined the Fiat 500 and confirmed that no defects were found on the car to contribute towards the collision.
Still to this day, the victim says she is trying to recover from the injuries sustained to her leg that will prevent her from continuing life as she did before.
“The incident is still very raw when I think about it,” the victim explained in her impact statement released by GMP. “I become upset when I think at everything which has been taken away from me and the ongoing affect it has had and continues to have on my daily life.”
GMP says it’s seeing the use of nitrous oxide being a factor in incidents they attend increasing year on year.
Nitrous oxide, also known as ‘laughing gas’, is reported to produce euphoria, relaxation, dizziness, giggling or laughing fits, impaired judgement, and occasionally dissociation and hallucinations – which GMP says affects reaction time and and is ‘likely lead to impairment’ in driving performance, particularly when faced with an unexpected or hazardous situation.
Tunstall appeared at Bolton Crown Court this week, and has been sentenced to one year and eight months imprisonment for having possession of a Class C drug, driving under the influence of drugs, and causing serious injury by dangerous driving.
Alongside being jailed, she was also disqualified from driving for two years and eight months, and has been ordered to take an extended test when she is released.